CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 3,932 shares at $35.94 ($141,316)
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change
- 4 Open-market sale Chief Executive Officer sold 10,031 shares at $41.23 ($413,578)
- 4 Open-market sale Chief Operating Officer sold 1,714 shares at $41.23 ($70,668)
- 4 Open-market sale Chief Financial Officer sold 2,197 shares at $41.23 ($90,582)
- 4 Open-market sale General Counsel and Secretary sold 3,185 shares at $41.23 ($131,318)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 3,762 shares at $41.80 ($157,252)
- 4 Derivatives Options or other derivatives
Page 7 of 45 · 883 filings